Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more
Darya-Varia Laboratoria Tbk - Asset Resilience Ratio
Darya-Varia Laboratoria Tbk (DVLA) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2024)
This chart shows how Darya-Varia Laboratoria Tbk's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Darya-Varia Laboratoria Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Darya-Varia Laboratoria Tbk maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Darya-Varia Laboratoria Tbk Industry Peers by Asset Resilience Ratio
Compare Darya-Varia Laboratoria Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Darya-Varia Laboratoria Tbk (2008–2024)
The table below shows the annual Asset Resilience Ratio data for Darya-Varia Laboratoria Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | Rp0.00 | Rp2.16 Trillion | -- |
| 2023-12-31 | 0.64% | Rp13.00 Billion | Rp2.04 Trillion | +2.75pp |
| 2022-12-31 | -2.11% | Rp-42.43 Billion | Rp2.01 Trillion | +0.05pp |
| 2021-12-31 | -2.16% | Rp-45.04 Billion | Rp2.09 Trillion | -2.79pp |
| 2020-12-31 | 0.63% | Rp12.59 Billion | Rp1.99 Trillion | +4.82pp |
| 2019-12-31 | -4.19% | Rp-76.61 Billion | Rp1.83 Trillion | -8.88pp |
| 2018-12-31 | 4.69% | Rp79.00 Billion | Rp1.68 Trillion | -14.08pp |
| 2017-12-31 | 18.77% | Rp308.00 Billion | Rp1.64 Trillion | +18.27pp |
| 2016-12-31 | 0.50% | Rp7.71 Billion | Rp1.53 Trillion | +0.04pp |
| 2015-12-31 | 0.47% | Rp6.43 Billion | Rp1.38 Trillion | +0.06pp |
| 2014-12-31 | 0.41% | Rp5.08 Billion | Rp1.24 Trillion | -0.14pp |
| 2013-12-31 | 0.55% | Rp6.50 Billion | Rp1.19 Trillion | +0.27pp |
| 2012-12-31 | 0.28% | Rp3.01 Billion | Rp1.07 Trillion | +0.03pp |
| 2009-12-31 | 0.25% | Rp1.98 Billion | Rp783.61 Billion | +0.08pp |
| 2008-12-31 | 0.17% | Rp1.08 Billion | Rp637.66 Billion | -- |